There was a 4-week open-label, dose optimization phase with VYVANSE (30 mg/day, 50 mg/day, or 70 mg/day in the morning)
Importantly, Retatrutide's unique triple receptor agonismtargeting GLP-1, GIP, and glucagon receptorsappears well-tolerated, with adverse events largely consistent with known effects from the broader GLP-1 class, primarily mild gastrointestinal symptoms such as nausea, decreased appetite, and occasional diarrhea, typically resolving within a few weeks of initiation
doi:10.1111/neup.12665 79
Glutathione and ROS scavenging Glutathione defends against reactive oxygen species that come from the respiratory chain
If taking a GLP-1 alongside a thyroid medication, a clinician may routinely order one or more of the following thyroid labs: TSH test : Measures thyroid-stimulating hormone (TSH) in the blood, though it cant show why TSH levels are too high or too low